α-突触核蛋白调节多巴胺神经传递。
Alpha-synuclein modulates dopamine neurotransmission.
作者信息
Butler Brittany, Sambo Danielle, Khoshbouei Habibeh
机构信息
University of Florida, Department of Neuroscience and Department of Psychiatry Gainesville, FL 32611.
University of Florida, Department of Neuroscience and Department of Psychiatry Gainesville, FL 32611.
出版信息
J Chem Neuroanat. 2017 Oct;83-84:41-49. doi: 10.1016/j.jchemneu.2016.06.001. Epub 2016 Jun 19.
Abstract
Alpha-synuclein is a small, highly charged protein encoded by the synuclein or SNCA gene that is predominantly expressed in central nervous system neurons. Although its physiological function remains enigmatic, alpha-synuclein is implicated in movement disorders such as Parkinson's disease, multiple system atrophy, and in neurodegenerative diseases such as Dementia with Lewy bodies. Here we have focused on reviewing the existing literature pertaining to wild-type alpha-synuclein structure, its properties, and its potential involvement in regulation of dopamine neurotransmission.
摘要
α-突触核蛋白是一种由突触核蛋白或SNCA基因编码的小的、高度带电的蛋白质，主要在中枢神经系统神经元中表达。尽管其生理功能仍然不明，但α-突触核蛋白与帕金森病、多系统萎缩等运动障碍以及路易体痴呆等神经退行性疾病有关。在此，我们着重回顾了与野生型α-突触核蛋白结构、其特性以及其在多巴胺神经传递调节中的潜在作用相关的现有文献。
相似文献
1
Alpha-synuclein modulates dopamine neurotransmission.α-突触核蛋白调节多巴胺神经传递。
J Chem Neuroanat. 2017 Oct;83-84:41-49. doi: 10.1016/j.jchemneu.2016.06.001. Epub 2016 Jun 19.
2
The role of α-synuclein in neurotransmission and synaptic plasticity.α-突触核蛋白在神经递质传递和突触可塑性中的作用。
J Chem Neuroanat. 2011 Dec;42(4):242-8. doi: 10.1016/j.jchemneu.2010.12.001. Epub 2010 Dec 16.
3
Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.脑内 α-突触核蛋白在多系统萎缩、帕金森病和进行性核上性麻痹中的蓄积：一项比较性研究。
Brain. 2010 Jan;133(Pt 1):172-88. doi: 10.1093/brain/awp282. Epub 2009 Nov 10.
4
AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.AAV1/2 诱导的 A53T-α-突触核蛋白在黑质中的过表达导致具有路易小体样病理学和运动障碍的黑质纹状体系统变性：帕金森病的新小鼠模型。
Acta Neuropathol Commun. 2017 Feb 1;5(1):11. doi: 10.1186/s40478-017-0416-x.
5
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.帕金森病患者脑脊液中α-突触核蛋白和tau 浓度：一项队列研究。
Lancet Neurol. 2011 Mar;10(3):230-40. doi: 10.1016/S1474-4422(11)70014-X.
6
Alpha-synuclein enhances dopamine D2 receptor signaling.α-突触核蛋白增强多巴胺D2受体信号传导。
Brain Res. 2006 Dec 8;1124(1):5-9. doi: 10.1016/j.brainres.2006.09.079. Epub 2006 Nov 7.
7
α-Synuclein A30P decreases neurodegeneration and increases synaptic vesicle release probability in CSPα-null mice.α-突触核蛋白 A30P 可减少 CSPα 基因敲除小鼠的神经退行性变并增加突触囊泡释放概率。
Neuropharmacology. 2014 Jan;76 Pt A:106-17. doi: 10.1016/j.neuropharm.2013.08.032. Epub 2013 Sep 11.
8
Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment.自噬调节α-突触核蛋白（SNCA/α-synuclein）的释放，从而产生一个不利的微环境。
Autophagy. 2014;10(12):2171-92. doi: 10.4161/auto.36436.
9
Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons.AAV 介导的α-突触核蛋白过表达诱导中脑多巴胺神经元进行性神经退行性变和行为改变。
Neurobiol Dis. 2012 Mar;45(3):939-53. doi: 10.1016/j.nbd.2011.12.013. Epub 2011 Dec 11.
10
Dopamine facilitates alpha-synuclein oligomerization in human neuroblastoma SH-SY5Y cells.多巴胺促进人神经母细胞瘤 SH-SY5Y 细胞中α-突触核蛋白寡聚化。
Biochem Biophys Res Commun. 2010 Jan 1;391(1):129-34. doi: 10.1016/j.bbrc.2009.11.015. Epub 2009 Nov 11.
引用本文的文献
1
Modulation of microbiota, inflammation, iron status and gene expression of affected receptors in Parkinson's disease rat model by synbiotic and dark chocolate.合生元和黑巧克力对帕金森病大鼠模型中微生物群、炎症、铁状态及受影响受体基因表达的调节作用
Sci Rep. 2025 Jul 4;15(1):23939. doi: 10.1038/s41598-025-08740-6.
2
Candidate Key Proteins of Tinnitus in the Auditory and Motor Systems of the Thalamus.丘脑听觉和运动系统中耳鸣的候选关键蛋白
Int J Mol Sci. 2025 Jun 17;26(12):5804. doi: 10.3390/ijms26125804.
3
Randomized controlled trial evaluating synbiotic supplementation as an adjuvant therapy in the treatment of Parkinson's disease.评估合生元补充剂作为帕金森病辅助治疗的随机对照试验。
Inflammopharmacology. 2025 May 28. doi: 10.1007/s10787-025-01752-8.
4
Alpha synuclein and inflammaging.α-突触核蛋白与炎症衰老
Heliyon. 2025 Jan 15;11(2):e41981. doi: 10.1016/j.heliyon.2025.e41981. eCollection 2025 Jan 30.
5
Crosstalk between gut-brain axis: unveiling the mysteries of gut ROS in progression of Parkinson's disease.肠脑轴的串扰：揭示肠道 ROS 在帕金森病进展中的奥秘。
Inflammopharmacology. 2024 Oct;32(5):2921-2941. doi: 10.1007/s10787-024-01510-2. Epub 2024 Jul 11.
6
Altered Sphingolipid Hydrolase Activities and Alpha-Synuclein Level in Late-Onset Schizophrenia.迟发性精神分裂症中鞘脂水解酶活性及α-突触核蛋白水平的改变
Metabolites. 2023 Dec 31;14(1):30. doi: 10.3390/metabo14010030.
7
Validity of CSF alpha-synuclein to predict psychosis in prodromal Alzheimer's disease.脑脊液α-突触核蛋白预测前驱期阿尔茨海默病患者发生精神病的效度
Front Neurol. 2023 May 24;14:1124145. doi: 10.3389/fneur.2023.1124145. eCollection 2023.
8
Impaired dopamine release in Parkinson's disease.帕金森病中多巴胺释放的受损。
Brain. 2023 Aug 1;146(8):3117-3132. doi: 10.1093/brain/awad064.
9
Polymorphic Alpha-Synuclein Oligomers: Characterization and Differential Detection with Novel Corresponding Antibodies.多形性α-突触核蛋白寡聚物：新型相应抗体的鉴定和差异检测。
Mol Neurobiol. 2023 May;60(5):2691-2705. doi: 10.1007/s12035-023-03211-3. Epub 2023 Jan 28.
10
α-synuclein enfolds tyrosine hydroxylase and dopamine ß-hydroxylase, potentially reducing dopamine and norepinephrine synthesis.α-突触核蛋白包裹酪氨酸羟化酶和多巴胺β-羟化酶，可能会减少多巴胺和去甲肾上腺素的合成。
J Proteins Proteom. 2022 Jun;13(2):109-115. doi: 10.1007/s42485-022-00088-z. Epub 2022 May 21.
本文引用的文献
1
Dopamine Transporter Activity Is Modulated by α-Synuclein.多巴胺转运体活性受α-突触核蛋白调节。
J Biol Chem. 2015 Dec 4;290(49):29542-54. doi: 10.1074/jbc.M115.691592. Epub 2015 Oct 6.
2
Exogenous α-synuclein decreases raft partitioning of Cav2.2 channels inducing dopamine release.外源性α-突触核蛋白减少 Cav2.2 通道的筏分，诱导多巴胺释放。
J Neurosci. 2014 Aug 6;34(32):10603-15. doi: 10.1523/JNEUROSCI.0608-14.2014.
3
The second sodium site in the dopamine transporter controls cation permeation and is regulated by chloride.多巴胺转运体中的第二个钠位点控制阳离子渗透，并受氯离子调节。
J Biol Chem. 2014 Sep 12;289(37):25764-73. doi: 10.1074/jbc.M114.574269. Epub 2014 Jul 25.
4
Reduced dopamine transporter expression in the amygdala of subjects diagnosed with schizophrenia.被诊断为精神分裂症的受试者杏仁核中多巴胺转运体表达降低。
Schizophr Bull. 2014 Sep;40(5):984-91. doi: 10.1093/schbul/sbu084. Epub 2014 Jun 16.
5
Missense dopamine transporter mutations associate with adult parkinsonism and ADHD.错义多巴胺转运体突变与成人帕金森病和注意力缺陷多动障碍相关。
J Clin Invest. 2014 Jul;124(7):3107-20. doi: 10.1172/JCI73778. Epub 2014 Jun 9.
6
Alpha-synuclein deletion decreases motor impulsivity but does not affect risky decision making in a mouse Gambling Task.α-突触核蛋白缺失可降低运动冲动性，但不影响小鼠赌博任务中的风险决策。
Psychopharmacology (Berl). 2014 Jun;231(12):2493-506. doi: 10.1007/s00213-013-3416-y. Epub 2014 Jan 9.
7
Region-specific deficits in dopamine, but not norepinephrine, signaling in a novel A30P α-synuclein BAC transgenic mouse.新型 A30P α-突触核蛋白 BAC 转基因小鼠多巴胺而非去甲肾上腺素信号的区域特异性缺陷。
Neurobiol Dis. 2014 Feb;62:193-207. doi: 10.1016/j.nbd.2013.10.005. Epub 2013 Oct 10.
8
Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model.多巴胺能传递的缺陷先于新帕金森模型中的神经元损失和功能障碍。
Proc Natl Acad Sci U S A. 2013 Oct 15;110(42):E4016-25. doi: 10.1073/pnas.1309143110. Epub 2013 Sep 30.
9
Effects of exogenous alpha-synuclein on stimulated dopamine overflow in dorsal striatum.外源性α-突触核蛋白对背侧纹状体中多巴胺溢出的影响。
Neurosci Lett. 2013 Oct 25;554:141-5. doi: 10.1016/j.neulet.2013.08.072. Epub 2013 Sep 8.
10
Polo-like kinase 2 regulates selective autophagic α-synuclein clearance and suppresses its toxicity in vivo.Polo-like kinase 2 调节选择性自噬 α-突触核蛋白清除，并在体内抑制其毒性。
Proc Natl Acad Sci U S A. 2013 Oct 8;110(41):E3945-54. doi: 10.1073/pnas.1309991110. Epub 2013 Aug 27.
Zotero 插件